Welcome to our dedicated page for Cellebrite DI Ltd. Warrants news (Ticker: CLBTW), a resource for investors and traders seeking the latest updates and insights on Cellebrite DI Ltd. Warrants stock.
Cellebrite DI Ltd is an Israeli digital intelligence company offering tools for law enforcement, enterprises, and service providers to collect, review, analyze, and manage digital data. Their products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, and more. They are known for their flagship solutions in the Cellebrite Case-to-Closure platform.
Cellebrite's mission as a global leader in Digital Investigative solutions is to enable customers to protect lives, accelerate justice, and preserve privacy globally. They empower organizations in legally sanctioned digital investigations and provide solutions that transform how data is collected, reviewed, analyzed, and managed.
Their recent announcement includes the launch of new SaaS solutions for remote data collection, focusing on efficiency and consent-based security.
Cellebrite (NASDAQ: CLBT) announced its Q1 2024 results, reporting a 27% year-over-year increase in Annual Recurring Revenue (ARR) to $331.8 million. Q1 2024 revenue rose by 26% to $89.6 million, driven by a 29% growth in subscription revenue. The company recorded a GAAP net loss of $71.4 million and a non-GAAP net income of $16.9 million. Adjusted EBITDA stood at $17.6 million with a 19.7% margin. CEO Yossi Carmil emphasized the global expansion and profitability improvements, noting the positive reception of new products like the Inseyets digital forensics software. The company reaffirmed its outlook for 2024, expecting ARR between $380 million and $400 million, and revenue between $370 million and $380 million for the full year.
Cellebrite (NASDAQ: CLBT), a global leader in digital investigative solutions, announced its participation in several investor conferences from May 26 to June 5, 2024. The company will engage in various formats, including fireside chats, 1x1 meetings, and presentations.
Key dates include May 26 at the Oppenheimer 25th Annual Israeli Conference, May 29 at the Craig-Hallum Institutional Investor Conference, May 30 at the TD Cowen 52nd Annual Technology, Media & Telecom Conference, and June 5 at the William Blair 44th Annual Growth Stock Conference.
Cellebrite executives like Dana Gerner (CFO), Andrew Kramer (VP), and Yossi Carmil (CEO) will present at these events. The conferences are opportunities for the company to highlight its digital investigative solutions and connect with investors.
FAQ
What is the current stock price of Cellebrite DI Ltd. Warrants (CLBTW)?
What products does Cellebrite offer?
What is Cellebrite's mission?
What recent announcement did Cellebrite make?
How does Cellebrite empower organizations?
